Univar Solutions Inc. - UNVR STOCK NEWS

Engine Capital LP, holding approximately 1% of Univar Solutions (NYSE: UNVR), has urged the Board of Directors to undertake an aggressive share repurchase program and consider strategic alternatives to address Univar's undervaluation. Following the company's $200 million accelerated buyback and $1 billion authorization, Engine welcomed indications of acquisition interest from Brenntag SE. They believe a competitive sale process could yield a purchase price between $38 and $44 per share, based on projected 2023 Adjusted EBITDA of $920 million.

On November 25, 2022, Univar Solutions Inc. (NYSE: UNVR) announced it received a preliminary indication of interest from Brenntag SE regarding a potential transaction. While the company has not detailed any plans, it has stated it will refrain from further comments until it deems appropriate. Univar Solutions is positioned as a global leader in specialty chemicals and ingredients, providing tailored solutions across various industries, supported by its significant logistics and technical capabilities.

Univar Solutions reported strong Q3 2022 results, with net income rising to $130 million (54% YoY) and earnings per share increasing to $0.78. Adjusted EBITDA reached $259.6 million, up 23.1% from the prior year. Total net sales were $2.983 billion, a 19.9% increase year-over-year, driven by pricing discipline and market share gains. The company also announced a $1 billion increase in its share repurchase authorization, showcasing its commitment to enhancing shareholder value. Full-year Adjusted EBITDA guidance remains at $1,050 million to $1,070 million.

Univar Solutions Inc. (NYSE: UNVR) has expanded its distribution agreement with Arkema to include organic peroxides for rubber and plastic additives in Belgium, France, and Turkey, starting January 1, 2023. This addition builds on their existing partnership covering Portugal and Spain. The organic peroxides, such as Luperox® and Retic®, enhance the production of rubber and plastics by improving strength and resistance. Univar aims to leverage its global footprint and technical support to address customer needs in various industries while promoting sustainable supply chains.

Univar Solutions (NYSE: UNVR) announced the establishment of new pharmaceutical ingredient laboratories at its Solution Centers in Houston, São Paulo, Mexico City, and Essen. These labs aim to enhance innovation and support drug development in the life sciences sector. Equipped with advanced analytical technology and staffed by pharmaceutical scientists, the facilities will offer services such as formulation development and performance testing. This strategic move positions Univar to meet evolving regulatory demands and support diverse applications in pharmaceuticals, biopharmaceuticals, and other segments.

Univar Solutions Inc. (NYSE: UNVR) will release its third quarter financial results on November 1, 2022, after market close. The company will also host a webcast on November 2, 2022, at 8:30 a.m. ET to discuss these results. Investors can access the webcast through the investor relations section of the company’s website. Univar Solutions is recognized for providing specialty ingredients and chemicals, supported by a strong logistics network and a substantial private transportation fleet.

Univar Solutions Inc. reported strong financial results for Q2 2022, achieving a net income of $162.9 million, a 6.3% increase from the previous year. Adjusted earnings per diluted share rose to $1.00 from $0.57. Total net sales reached $3.0 billion, up 26.0% year-over-year, driven by successful pricing strategies and market share gains. Adjusted EBITDA surged to $291.6 million, a 47.6% increase. The company raised its full-year adjusted EBITDA guidance to $1,040 million - $1,080 million.

Univar Solutions announced its acquisition of Vicom Distribución Productos Quimicos, a leading specialty chemicals distributor in Spain and Portugal, enhancing its specialty portfolio with advanced additive solutions. This strategic move is expected to strengthen Univar's presence in Europe and aligns with its growth priorities, fostering deeper market offerings in coatings, adhesives, sealants, and elastomers. The acquisition aims to leverage Vicom's strong supplier partnerships and sales expertise, although financial terms were not disclosed.

Univar Solutions (NYSE: UNVR) announces an exclusive marketing and distribution agreement between its division NexusBioAg and MustGrow Biologics Corp. This collaboration focuses on bringing TerraMG™, a mustard-derived biopesticide, to the Canadian canola and pulse markets. The product aims to tackle crop diseases such as ClubRoot and Aphanomyces, enhancing NexusBioAg's portfolio of agricultural solutions. The technology is not yet registered with Canada's Pest Management Regulatory Agency, but it showcases a commitment to sustainable farming solutions.